P2Y Receptors in Synaptic Transmission and Plasticity: Therapeutic Potential in Cognitive Dysfunction

ATP released from neurons and astrocytes during neuronal activity or under pathophysiological circumstances is able to influence information flow in neuronal circuits by activation of ionotropic P2X and metabotropic P2Y receptors and subsequent modulation of cellular excitability, synaptic strength,...

Full description

Bibliographic Details
Main Authors: Segundo J. Guzman, Zoltan Gerevich
Format: Article
Language:English
Published: Hindawi Limited 2016-01-01
Series:Neural Plasticity
Online Access:http://dx.doi.org/10.1155/2016/1207393
id doaj-5120b6f7e91241259774d53e8f786f62
record_format Article
spelling doaj-5120b6f7e91241259774d53e8f786f622020-11-24T21:05:15ZengHindawi LimitedNeural Plasticity2090-59041687-54432016-01-01201610.1155/2016/12073931207393P2Y Receptors in Synaptic Transmission and Plasticity: Therapeutic Potential in Cognitive DysfunctionSegundo J. Guzman0Zoltan Gerevich1Institute of Science and Technology Austria (IST Austria), Am Campus 1, 3400 Klosterneuburg, AustriaInstitute of Neurophysiology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, GermanyATP released from neurons and astrocytes during neuronal activity or under pathophysiological circumstances is able to influence information flow in neuronal circuits by activation of ionotropic P2X and metabotropic P2Y receptors and subsequent modulation of cellular excitability, synaptic strength, and plasticity. In the present paper we review cellular and network effects of P2Y receptors in the brain. We show that P2Y receptors inhibit the release of neurotransmitters, modulate voltage- and ligand-gated ion channels, and differentially influence the induction of synaptic plasticity in the prefrontal cortex, hippocampus, and cerebellum. The findings discussed here may explain how P2Y1 receptor activation during brain injury, hypoxia, inflammation, schizophrenia, or Alzheimer’s disease leads to an impairment of cognitive processes. Hence, it is suggested that the blockade of P2Y1 receptors may have therapeutic potential against cognitive disturbances in these states.http://dx.doi.org/10.1155/2016/1207393
collection DOAJ
language English
format Article
sources DOAJ
author Segundo J. Guzman
Zoltan Gerevich
spellingShingle Segundo J. Guzman
Zoltan Gerevich
P2Y Receptors in Synaptic Transmission and Plasticity: Therapeutic Potential in Cognitive Dysfunction
Neural Plasticity
author_facet Segundo J. Guzman
Zoltan Gerevich
author_sort Segundo J. Guzman
title P2Y Receptors in Synaptic Transmission and Plasticity: Therapeutic Potential in Cognitive Dysfunction
title_short P2Y Receptors in Synaptic Transmission and Plasticity: Therapeutic Potential in Cognitive Dysfunction
title_full P2Y Receptors in Synaptic Transmission and Plasticity: Therapeutic Potential in Cognitive Dysfunction
title_fullStr P2Y Receptors in Synaptic Transmission and Plasticity: Therapeutic Potential in Cognitive Dysfunction
title_full_unstemmed P2Y Receptors in Synaptic Transmission and Plasticity: Therapeutic Potential in Cognitive Dysfunction
title_sort p2y receptors in synaptic transmission and plasticity: therapeutic potential in cognitive dysfunction
publisher Hindawi Limited
series Neural Plasticity
issn 2090-5904
1687-5443
publishDate 2016-01-01
description ATP released from neurons and astrocytes during neuronal activity or under pathophysiological circumstances is able to influence information flow in neuronal circuits by activation of ionotropic P2X and metabotropic P2Y receptors and subsequent modulation of cellular excitability, synaptic strength, and plasticity. In the present paper we review cellular and network effects of P2Y receptors in the brain. We show that P2Y receptors inhibit the release of neurotransmitters, modulate voltage- and ligand-gated ion channels, and differentially influence the induction of synaptic plasticity in the prefrontal cortex, hippocampus, and cerebellum. The findings discussed here may explain how P2Y1 receptor activation during brain injury, hypoxia, inflammation, schizophrenia, or Alzheimer’s disease leads to an impairment of cognitive processes. Hence, it is suggested that the blockade of P2Y1 receptors may have therapeutic potential against cognitive disturbances in these states.
url http://dx.doi.org/10.1155/2016/1207393
work_keys_str_mv AT segundojguzman p2yreceptorsinsynaptictransmissionandplasticitytherapeuticpotentialincognitivedysfunction
AT zoltangerevich p2yreceptorsinsynaptictransmissionandplasticitytherapeuticpotentialincognitivedysfunction
_version_ 1716769423175450624